# Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality

Study · id `cardio:ct-nct02961946` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02961946](<https://clinicaltrials.gov/study/NCT02961946>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02961946

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 198 participants.

## Technical summary

Registry record NCT02961946. Randomized; single masking; primary purpose diagnostic. Start 2017-03-15 (actual); primary completion 2017-10-31 (actual). Results posted on 2019-09-17.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose diagnostic
- Phase: Phase 4
- Enrolled: 198 participants (enrolled count; ClinicalTrials.gov record NCT02961946, source copy `cardio:ctgov-nct02961946-2019-09-17`, retrieved 2026-10-26)
- Started: 2017-03-15 (actual) (ClinicalTrials.gov record NCT02961946, source copy `cardio:ctgov-nct02961946-2019-09-17`, retrieved 2026-10-26)
- Primary completion: 2017-10-31 (actual) (ClinicalTrials.gov record NCT02961946, source copy `cardio:ctgov-nct02961946-2019-09-17`, retrieved 2026-10-26)
- Completion: 2018-08-02 (actual) (ClinicalTrials.gov record NCT02961946, source copy `cardio:ctgov-nct02961946-2019-09-17`, retrieved 2026-10-26)
- Results first posted: 2019-09-17 (ClinicalTrials.gov record NCT02961946, source copy `cardio:ctgov-nct02961946-2019-09-17`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02961946, source copy `cardio:ctgov-nct02961946-2019-09-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02961946-2019-09-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Sublingual and Transdermal Administration of Nitroglycerin for Coronary CT Angiography on Image Quality
- Condition: Coronary Artery Disease
- Intervention (Drug): Nitroglycerin
- Lead sponsor: Massachusetts General Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Massachusetts General Hospital (`cardio:org-massachusetts-general-hospital`)

## Provenance

Content hash: c3ade27cac6bd95c27c8a772e385a6e1a0b8bd1ed3213c245f6cae4300fe5556
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
